Publication and Peer-review Process
Criteria for publication
The Oncology Nurse-APN/PA considers the following types of articles:
Research: reports of data from original research.
Reviews: comprehensive, authoritative descriptions of any subject within the publication’s scope. Reviews can cover any topical themes such as basic science and clinical reviews, ethics, pro/con debates, equipment reviews, therapeutic reviews, and thematic series to highlight specific topics in the field.
Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. These can also be used to present unexpected or unusual images of a disease. All case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians.
Letters to the Editor: brief clinical studies should be submitted in this format for rapid communication. Reports of individual cases that may impact and/or enhance clinical practice or diagnostic understanding can also be submitted in this format. These can also take other forms: a substantial reanalysis of a previously published article, or a substantial response to such a reanalysis from the authors of the original publication, or an article that may not cover “standard research” but that may be relevant to readers.
Rapid communications: preliminary results of significant interest that are particularly topical and relevant, and for which fast publication is essential.
Peer-review policies
By submission: The Oncology Nurse-APN/PA has a “closed” peer-review policy. All submitted manuscripts will be screened before being sent to two peer reviewers. The Editor-in-Chief and Associate Editors are routinely involved in decision-making, but final decisions lie with the Editor-in-Chief. The publication aims to reach a first decision within six weeks. If an author has queries or is unsatisfied with a decision, there will be a discussion involving the Editor-in-Chief and at least one of the Associate Editors who was not involved in the initial review.
Independently developed medical communications: all reviews, case reports, expert interviews, product profilers (e.g., RxProfiler™), and continuing education articles independently developed and written by The Oncology Nurse-APN/PA will be sent to two peer reviewers. The Editor-in-Chief and Associate Editors are routinely involved in decision-making, but final decisions lie with the Editor-in-Chief. The publication aims to reach a first decision within six weeks. If an author has queries or is unsatisfied with a decision, there will be a discussion involving the Editor-in-Chief and at least one of the Associate Editors who was not involved in the initial review.
The Oncology Nurse-APN/PA is supported by an expert Editorial Board.
Reprints
High-quality, bound reprints can be purchased for all articles published. Please contact our sales and marketing team for further information about ordering reprints, and to enquire about further details, including fees.
Supplements
The Oncology Nurse-APN/PA will consider supplements based on proceedings (full articles or meeting abstracts), reviews, or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.
Cordially yours,
EDITOR-IN-CHIEF
Beth Faiman, RN, MSN, APRN, BC, AOCN
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH